Grace Therapeutics, Inc.GRCEEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Delix Therapeutics is an American biotech company based in Boston, Massachusetts. The company develops novel neuroplasticity-promoting therapeutics for central nervous system (CNS) diseases such as depression and post-traumatic stress disorder (PTSD). It was co-founded in 2019 by David E. Olson and Nick Haft.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 9.99% | 1.0M | ▼ -0.21pp | 2024-11-14 |
| s. AIGH Capital Management, LLC | 6.00% | 567.8K | — | 2024-04-09 |
| NOS. OF ABOVE PERSONS | 4.90% | 494.7K | ▼ -0.40pp | 2024-11-14 |